AAAAAA
Results: 176-200/265
Authors:
Mottet, N
Costa, P
Navratil, H
Citation: N. Mottet et al., Intermittent versus continuous hormone deprivation in metastatic prostate cancer: preliminary data from an ongoing European study, PROSTATE C, 2, 1999, pp. S2-S4
Authors:
Zattoni, F
Valotto, C
Bierti, S
Citation: F. Zattoni et al., Immediate or deferred hormone ablation in PSA relapse after radical prostatectomy, PROSTATE C, 2, 1999, pp. S5-S7
Authors:
Teillac, P
Citation: P. Teillac, Is there a place for neoadjuvant hormonal therapy before radical prostatectomy or radiation therapy in the management of prostate cancer?, PROSTATE C, 2, 1999, pp. S8-S11
Authors:
Kurek, R
Tunn, UW
Aumuller, G
Renneberg, H
Citation: R. Kurek et al., Will modern molecular methods such as reverse transcriptase-polymerase chain reaction improve the prediction of prognosis in prostate cancer patients?, PROSTATE C, 2, 1999, pp. S12-S14
Authors:
Altwein, JE
Luboldt, HA
Citation: Je. Altwein et Ha. Luboldt, Results of a screening program in Germany for early detection of early prostate cancer, PROSTATE C, 2, 1999, pp. S15-S18
Authors:
Altwein, J
Citation: J. Altwein, GnRH analogues and prostate cancer - Proceedings of the sponsored symposium to the 5th International Symposium on GnRH Analogues in Cancer and Human Reproduction - February 6, 1999, Hotel Intercontinental Geneve, Geneva, Switzerland - Summary, PROSTATE C, 2, 1999, pp. S19-S19
Authors:
Belldegrun, A
Citation: A. Belldegrun, What's hot in the prostate?, PROSTATE C, 2(1), 1999, pp. 1-2
Authors:
Kirby, R
Sher, H
Brawer, M
Citation: R. Kirby et al., Untitled, PROSTATE C, 2(1), 1999, pp. 3-3
Authors:
Bennett, CL
Tosteson, TD
Schmitt, B
Weinberg, PD
Ernstoff, MS
Ross, SD
Citation: Cl. Bennett et al., Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide, PROSTATE C, 2(1), 1999, pp. 4-8
Authors:
Eeles, RA
Citation: Ra. Eeles, Genetic predisposition to prostate cancer, PROSTATE C, 2(1), 1999, pp. 9-15
Authors:
Tizzani, A
Gontero, P
Casetta, G
Piana, P
Baima, C
de Zan, A
Bodo, G
Pacchioni, D
Citation: A. Tizzani et al., Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results, PROSTATE C, 2(1), 1999, pp. 16-20
Authors:
Salomon, L",Colombel,"Patard, JJ
Herard, A
Gasman, D
Chopin, D
Abbou, CC
Citation: Jj. Salomon, L",colombel,"patard et al., Eight year improvement in pathological results after radical prostatectomy, PROSTATE C, 2(1), 1999, pp. 21-24
Authors:
Andrawiss, M
Opolon, P
Benihoud, K
Devauchelle, P
Di Falco, N
Villette, JM
Kremer, E
Saulnier, P
Berthon, P
Perricaudet, M
Cussenot, O
Citation: M. Andrawiss et al., Adenovirus-mediated gene transfer in dog prostate: a preclinical study of a relevant model system for gene therapy of human prostatic cancer, PROSTATE C, 2(1), 1999, pp. 25-35
Authors:
Bex, A
Lummen, G
Rembrink, K
Otto, T
Metz, K
Rubben, H
Citation: A. Bex et al., Influence of pertussis toxine on local progression and metastasis after orthotopic implantation of the human prostate cancer cell line PC3 in nude mice, PROSTATE C, 2(1), 1999, pp. 36-40
Authors:
Sepp-Lorenzino, L
Balog, A
Su, DS
Meng, D
Timaul, N
Scher, HI
Danishefsky, SJ
Rosen, N
Citation: L. Sepp-lorenzino et al., The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells, PROSTATE C, 2(1), 1999, pp. 41-52
Authors:
Lukacs, B
Citation: B. Lukacs, Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice (vol 1, pg 276, 1998), PROSTATE C, 2(1), 1999, pp. 53-53
Authors:
Brawer, MK
Citation: Mk. Brawer, 8th International Prostate Cancer Update - 28th January-1st February 1998 - Beaver Creek, Colorado, USA - Introduction, PROSTATE C, 2, 1999, pp. 1-1
Authors:
Brawer, MK
Citation: Mk. Brawer, Prostate cancer: epidemiology and screening, PROSTATE C, 2, 1999, pp. 2-6
Authors:
Sakr, WA
Brawer, MK
Moul, JW
Donohue, R
Schulman, CG
Citation: Wa. Sakr et al., Pathology and bio markers of prostate cancer, PROSTATE C, 2, 1999, pp. 7-14
Authors:
Lilja, H
Citation: H. Lilja, Early diagnosis and staging, PROSTATE C, 2, 1999, pp. 15-18
Authors:
Glode, LM
Petrylak, DP
Citation: Lm. Glode et Dp. Petrylak, Refractory disease, new horizons and patient-physician relationships, PROSTATE C, 2, 1999, pp. 19-20
Authors:
Ziada, AM
Crawford, ED
Citation: Am. Ziada et Ed. Crawford, Advanced prostate cancer, PROSTATE C, 2, 1999, pp. 21-26
Authors:
Kelloff, GJ
Lieberman, R
Brawer, MK
Crawford, ED
Labrie, F
Miller, GJ
Citation: Gj. Kelloff et al., Strategies for chemoprevention of prostate cancer, PROSTATE C, 2, 1999, pp. 27-33
Authors:
Nickel, JC
Citation: Jc. Nickel, Medical therapy for BPH: expanding our treatment paradigm?, PROSTATE C, 2, 1999, pp. 34-38
Authors:
Donohue, R
Citation: R. Donohue, Eighth International Prostate Cancer Update, Abstracts, Beaver Creek, Colorado, 28th January to 1st February, 1998, PROSTATE C, 2, 1999, pp. 39-43